We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

By LabMedica International staff writers
Posted on 22 Sep 2025

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. More...

Standard care can be hindered by delays in identifying the type of transfusion needed to stop bleeding. Now, a real-time blood-monitoring approach has shown potential to provide rapid, detailed insights into clotting, bringing hospitals closer to faster and more effective emergency care.

Researchers from the Keck School of Medicine of USC (Los Angeles, CA, USA) conducted a comprehensive review of viscoelastic testing (VET), a minimally invasive diagnostic technology. VET detects how well blood is clotting and identifies which blood components—such as plasma, platelets or whole blood—are most effective for treating hemorrhage. Already approved by the U.S. FDA for use in surgeries and trauma, the test is not yet standard in maternity care.

The review analyzed findings from 156 studies and included interviews with patients, providers and policymakers. Evidence suggests VET can improve management of postpartum hemorrhage, but only two randomized controlled trials were identified, highlighting the need for stronger data. The review, published in the International Journal of Obstetric Anesthesia, underscores that large-scale U.S.-based research is essential to confirm its clinical impact in maternity settings.

Adopting VET could reduce maternal deaths and improve precision in transfusion practices, preventing unnecessary use of costly whole blood products. Its potential extends beyond survival benefits, with implications for reducing health disparities, as Black women and women in rural areas face higher maternal mortality rates. Researchers recommend multicenter randomized trials and standardized protocols to guide adoption, ensuring VET is implemented effectively in obstetric care.

“Because it is a point-of-care test that can be done at a patient’s bedside, it provides fast and detailed results within minutes, helping physicians make treatment decisions in real time,” said Carla Janzen, MD, PhD, first author of the publication.

Related Links:
Keck School of Medicine of USC


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The platform analyzes cell-free DNA in blood, searching for minute amounts of tumor-derived fragments among background DNA (Image Credit: Adobe Stock)

Blood Test Could Help Fast-Track Lymphoma Diagnosis in Resource-Limited Settings

Lymphoma can be difficult to distinguish from infections and benign conditions, while definitive diagnosis often depends on surgical tissue sampling and specialized pathology that may not be readily available.... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.